# Colchicine Effect on Perivascular Inflammation Index on Coronary CTA

> **NCT05347316** · PHASE1 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Atherosclerosis
- Inflammatory Response
- Coronary Disease

## Interventions

- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT05347316
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-07
- **Primary completion:** 2023-03-07
- **Final completion:** 2025-03-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05347316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05347316, "Colchicine Effect on Perivascular Inflammation Index on Coronary CTA". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05347316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*